New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01

Adult Humans Adolescent Tuberculosis Vaccines BCG Vaccine Mycobacterium tuberculosis Immunization, Secondary Tuberculosis / epidemiology Vaccination India / epidemiology
Budget impact Cost-effectiveness Health impact Mathematical modelling Tuberculosis Vaccines

Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
04 08 2023
Historique:
received: 24 02 2023
accepted: 20 07 2023
medline: 7 8 2023
pubmed: 5 8 2023
entrez: 4 8 2023
Statut: epublish

Résumé

India had an estimated 2.9 million tuberculosis cases and 506 thousand deaths in 2021. Novel vaccines effective in adolescents and adults could reduce this burden. M72/AS01 We developed an age-stratified compartmental tuberculosis transmission model for India calibrated to country-specific epidemiology. We projected baseline epidemiology to 2050 assuming no-new-vaccine introduction, and M72/AS01 M72/AS01 M72/AS01

Sections du résumé

BACKGROUND
India had an estimated 2.9 million tuberculosis cases and 506 thousand deaths in 2021. Novel vaccines effective in adolescents and adults could reduce this burden. M72/AS01
METHODS
We developed an age-stratified compartmental tuberculosis transmission model for India calibrated to country-specific epidemiology. We projected baseline epidemiology to 2050 assuming no-new-vaccine introduction, and M72/AS01
RESULTS
M72/AS01
CONCLUSIONS
M72/AS01

Identifiants

DOI: 10.1186/s12916-023-02992-7 PMID: 37542319 PMC: PMC10403932
pubmed: 37542319
doi: 10.1186/s12916-023-02992-7
pii: 10.1186/s12916-023-02992-7
pmc: PMC10403932
doi:

Substances chimiques

Tuberculosis Vaccines 0
BCG Vaccine 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

288

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Bill & Melinda Gates Foundation
ID : INV-001754
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

BMJ Glob Health. 2018 Nov 5;3(6):e000964
pubmed: 30483412
PLoS Comput Biol. 2015 Jan 08;11(1):e1003968
pubmed: 25569850
Clin Infect Dis. 2001 Oct 1;33(7):1034-9
pubmed: 11528577
J Antimicrob Chemother. 2017 Apr 1;72(4):1243-1252
pubmed: 28073970
Epidemiol Infect. 1997 Oct;119(2):183-201
pubmed: 9363017
J Intern Med. 2020 Dec;288(6):661-681
pubmed: 33128834
Clin Infect Dis. 2014 Jun;58(12):1676-83
pubmed: 24647020
Epidemics. 2019 Dec 2;30:100381
pubmed: 31846721
Int J Tuberc Lung Dis. 2017 Apr 1;21(4):366-374
pubmed: 28284250
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15520-5
pubmed: 25288770
PLoS Med. 2023 Jul 11;20(7):e1004252
pubmed: 37432972
Proc Biol Sci. 2004 Mar 22;271(1539):617-23
pubmed: 15156920
Sci Transl Med. 2020 Oct 7;12(564):
pubmed: 33028708
Proc Biol Sci. 2021 Jan 27;288(1943):20201635
pubmed: 33467995
BMJ Glob Health. 2023 Jul;8(7):
pubmed: 37438049
Value Health. 2016 Dec;19(8):921-928
pubmed: 27987641
Tubercle. 1982 Dec;63(4):255-68
pubmed: 6763793
Indian J Med Res. 1999 Aug;110:56-69
pubmed: 10573656
PLoS Med. 2023 Jan 24;20(1):e1004155
pubmed: 36693081
Clin Infect Dis. 2014 Feb;58(4):470-80
pubmed: 24336911
J R Stat Soc Ser C Appl Stat. 2017 Aug;66(4):717-740
pubmed: 28781386
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13980-5
pubmed: 19666590
J R Soc Interface. 2008 Jun 6;5(23):653-62
pubmed: 17690054
N Engl J Med. 2019 Dec 19;381(25):2429-2439
pubmed: 31661198
Int J Tuberc Lung Dis. 2021 Dec 1;25(12):1013-1018
pubmed: 34886932
J Theor Biol. 2007 Oct 21;248(4):608-17
pubmed: 17669435
BMC Med. 2017 Mar 3;15(1):47
pubmed: 28253922
N Engl J Med. 2018 Jul 12;379(2):138-149
pubmed: 29996082
PLoS Comput Biol. 2021 Jul 26;17(7):e1009098
pubmed: 34310590
Indian J Med Res. 2023 Feb-Mar;157(2&3):152-159
pubmed: 36124494
Indian J Tuberc. 2019 Jan;66(1):150-157
pubmed: 30797274
Int Health. 2021 Dec 1;13(6):536-544
pubmed: 33570132
BMC Med. 2021 Feb 26;19(1):60
pubmed: 33632218
F1000Res. 2019 Mar 26;8:338
pubmed: 31297190
PLOS Glob Public Health. 2022 May 3;2(5):e0000076
pubmed: 36962104
PLoS Med. 2011 Nov;8(11):e1001120
pubmed: 22087078
PLoS One. 2018 Mar 12;13(3):e0193396
pubmed: 29529036
BMC Pulm Med. 2018 May 3;18(1):66
pubmed: 29724218
Lancet Glob Health. 2023 Apr;11(4):e546-e555
pubmed: 36925175
PLoS One. 2011 Apr 04;6(4):e17601
pubmed: 21483732
Am J Epidemiol. 2017 Dec 15;186(12):1362-1369
pubmed: 29253139
Lancet Respir Med. 2020 Apr;8(4):332-333
pubmed: 32057300
Public Health Action. 2020 Sep 21;10(3):110-117
pubmed: 33134125
Trop Med Int Health. 2020 Jul;25(7):803-812
pubmed: 32306481
Pharmacoeconomics. 2008;26(2):163-78
pubmed: 18198935
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Clin Infect Dis. 2021 Aug 2;73(3):e830-e841
pubmed: 32936877

Auteurs

Rebecca A Clark (RA)

TB Modelling Group and TB Centre, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. Rebecca.Clark@lshtm.ac.uk.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK. Rebecca.Clark@lshtm.ac.uk.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. Rebecca.Clark@lshtm.ac.uk.
Vaccine Centre, London School of Hygiene and Tropical Medicine, London, UK. Rebecca.Clark@lshtm.ac.uk.
ORCID: 0000-0001-8923-0301

Chathika K Weerasuriya (CK)

TB Modelling Group and TB Centre, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Allison Portnoy (A)

Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, USA.
Department of Global Health, Boston University School of Public Health, Boston, USA.

Christinah Mukandavire (C)

TB Modelling Group and TB Centre, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Matthew Quaife (M)

TB Modelling Group and TB Centre, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Roel Bakker (R)

TB Modelling Group and TB Centre, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
KNCV Tuberculosis Foundation, The Hague, Netherlands.

Danny Scarponi (D)

TB Modelling Group and TB Centre, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Rebecca C Harris (RC)

TB Modelling Group and TB Centre, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Sanofi Pasteur, Singapore, Singapore.

Kirankumar Rade (K)

World Health Organization, New Delhi, India.

Sanjay Kumar Mattoo (SK)

Central TB Division, NTEP, MoHFW Govt of India, New Delhi, India.

Dheeraj Tumu (D)

World Health Organization, New Delhi, India.
Central TB Division, NTEP, MoHFW Govt of India, New Delhi, India.

Nicolas A Menzies (NA)

Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, USA.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, USA.

Richard G White (RG)

TB Modelling Group and TB Centre, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Vaccine Centre, London School of Hygiene and Tropical Medicine, London, UK.
ORCID: 0000-0003-4410-6635

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antibactériens › Vaccins antituberculeux › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antibactériens › Vaccins antituberculeux › Vaccin BCG › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Rappel de vaccin › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › New tuberculosis vaccines in India: modelling...
questionsmedicales.fr › Régions géographiques › Asie › Asie de l'Ouest › Asie du Sud › Inde › New tuberculosis vaccines in India: modelling...